75 results
8-K
EVOK
Evoke Pharma Inc
18 Mar 24
Other Events
5:02pm
compliance with the Minimum Stockholders’ Equity Requirement on a long-term basis, including the equity financing completed in February 2024, which provided
424B3
EVOK
Evoke Pharma Inc
14 Mar 24
Prospectus supplement
6:44pm
other employees, non-employee directors and consultants. The principal purposes of our long-term, equity-based incentive awards are to align … . These relationships or those like them may require us to incur non-recurring and other charges, increase our near- and long-term expenditures, issue
8-K
EX-99.1
2sa4qrk
14 Mar 24
Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results
4:00pm
8-K
EX-1.1
ino20uc5g68w
9 Feb 24
Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
5:15pm
424B4
b76wf4ag2g1fv qhd
9 Feb 24
Prospectus supplement with pricing info
5:14pm
8-K
EX-99.1
qq2b0aeowh3 taa
9 Nov 23
Evoke Pharma Reports Third Quarter 2023 Financial Results
9:00am